Sign in
4

Changes in Ownership

Wave Life Sciences, Inc. Filed Acc 0000899243-22-017133

Chief Financial Officer sold 5,021 shares at $1.72 ($8,636)

  • Chief Financial Officer acquired 15,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Moran Kyle · Chief Financial Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2022-05-04 Grant or award : show line 1 in the form +15,000 89,588 D
2022-05-05 Sale : show line 2 in the form −5,021 $1.72 $8,636 84,567 D
Open-market sales · 5,021 sh · avg $1.72 · $8,636
Loading xslF345X03/doc4.xml…